WIN $150 GIFT VOUCHERS: ALADDIN'S GOLD

Close Notification

Your cart does not contain any items

Non-Alcoholic Fatty Liver Disease, An Issue of Clinics in Liver Disease

Paul J. Gaglio (Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY)

$163.95

Hardback

Not in-store but you can order this
How long will it take?

QTY:

English
Elsevier - Health Sciences Division
15 April 2016
Due to the current obesity epidemic, non-alcoholic fatty liver disease (NAFLD) is prevalent in a significant portion of the United States patient population. It is being increasingly recognized that NAFLD affects both adults and children and can progress to end stage liver disease with resultant cirrhosis, portal hypertension, and hepatocellular carcinoma. In addition, several extrahepatic conditions may be linked to NAFLD including cardiovascular disease, insulin requiring and type 2 diabetes mellitus, obstructive sleep apnea, colonic adenomas, hyperuricemia, vitamin D deficiency, hyperferritinemia, pancreatic steatosis, hypothyroidism, and polycystic ovarian syndrome. Therapies for NAFLD are evolving rapidly. This issue will analyze patient demographics, risk factors, pathophysiology, patient presentation, and treatments for NAFLD.
By:  
Imprint:   Elsevier - Health Sciences Division
Country of Publication:   United States
Volume:   20-2
Dimensions:   Height: 229mm,  Width: 152mm,  Spine: 18mm
Weight:   520g
ISBN:   9780323416962
ISBN 10:   0323416969
Series:   The Clinics: Internal Medicine
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

See Also